SIGN UP
LOG IN
Levi Strauss To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday
Benzinga·05/15/2025 12:32:50
Listen to the news
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Needham cut Endava plc (NYSE:DAVA) price target from $22 to $18. Needham analyst Mayank Tandon maintained a Buy rating. Endava shares closed at $15.64 on Wednesday. See how other analysts view this stock.
- Wells Fargo increased the price target for Cisco Systems, Inc. (NASDAQ:CSCO) from $72 to $75. Wells Fargo analyst Aaron Rakers upgraded the stock from Equal-Weight to Overweight. Cisco shares closed at $61.29 on Wednesday. See how other analysts view this stock.
- Rosenblatt boosted Nexxen International Ltd. (NASDAQ:NEXN) price target from $15 to $16. Rosenblatt analyst Barton Crockett maintained a Buy rating. Nexxen International shares closed at $11.62 on Wednesday. See how other analysts view this stock.
- Needham raised the price target for Ibotta, Inc. (NYSE:IBTA) from $60 to $70. Needham analyst Bernie McTernan maintained a Buy rating. Ibotta shares closed at $50.13 on Wednesday. See how other analysts view this stock.
- Telsey Advisory Group slashed the price target for Grove Collaborative Holdings, Inc. (NYSE:GROV) from $2 to $1.2. Telsey Advisory Group analyst Dana Telsey downgraded the stock from Outperform to Market Perform. Grove Collaborative shares closed at $1.19 on Wednesday. See how other analysts view this stock.
- HC Wainwright & Co. raised Sanara MedTech Inc. (NASDAQ:SMTI) price target from $51 to $53. HC Wainwright & Co. analyst Yi Chen maintained a Buy rating. Sanara MedTech shares settled at $31.30 on Wednesday. See how other analysts view this stock.
- Canaccord Genuity slashed Annovis Bio, Inc. (NASDAQ:ANVS) price target from $26 to $17. Canaccord Genuity analyst Sumant Kulkarni maintained a Buy rating. Annovis Bio shares closed at $1.69 on Wednesday. See how other analysts view this stock.
- Chardan Capital cut Metagenomi, Inc. (NASDAQ:MGX) price target from $13 to $12. Chardan Capital analyst Geulah Livshits maintained a Buy rating. Metagenomi shares closed at $1.50 on Wednesday. See how other analysts view this stock.
- Telsey Advisory Group increased the price target for Levi Strauss & Co. (NYSE:LEVI) from $19 to $21. Telsey Advisory Group analyst Dana Telsey maintained an Outperform rating. Levi Strauss shares settled at $17.53 on Wednesday. See how other analysts view this stock.
- JP Morgan raised Cisco Systems, Inc. (NASDAQ:CSCO) price target from $70 to $73. JP Morgan analyst Samik Chatterjee maintained an Overweight rating. Cisco shares closed at $61.29 on Wednesday. See how other analysts view this stock.
Considering buying LEVI stock? Here’s what analysts think:
Read This Next:
Photo via Shuttterstock
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.